COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 376
[20] Mutter J, et al. Alzheimer disease: mercury as pathogenetic
factor and apolipoprotein E as a moderator. Neuro Endocrinol
Lett. 2004;25(5):331-339.
[21] Vojdani A, et al. Foods cross-reactive with amyloid-beta
peptide: a potential risk factor for Alzheimer's disease. J Alzheimers
Dis. 2018;65(3):1123-1135.
[22] Vojdani A, Vojdani E. Food-associated autoimmunities: when
food breaks your immune system. Autoimmune Dis.
2016;2016:4120316.
[23] Zlokovic BV. The blood-brain barrier in health and chronic
neurodegenerative disorders. Neuron. 2008;57(2):178-201.
[24] Nation DA, et al. Blood-brain barrier breakdown is an early
biomarker of human cognitive dysfunction. Nat Med.
2019;25(2):270-276.
[25] Cyrex Laboratories. Clinical applications and interpretation
guide: Alzheimer's LINX. 2022.
[26] Vojdani A. A potential link between environmental triggers
and autoimmunity. Autoimmune Dis. 2014;2014:437231.
[27] Bredesen DE. Reversal of cognitive decline: a novel
therapeutic program. Aging. 2014;6(9):707-717.
[28] Bredesen DE, et al. Reversal of cognitive decline in Alzheimer's
disease. Aging. 2016;8(6):1250-1258.
[29] Bredesen DE, et al. Metabolic profiling distinguishes three
subtypes of Alzheimer's disease. Aging. 2015;7(8):595-600.
[30] Toups K, et al. Precision medicine approach to Alzheimer's
disease: successful pilot project. J Alzheimers Dis. 2022;88(1):1-15.
[31] Dale E, et al. Clinicopathological correlations in a case of
early-onset Alzheimer's disease with atypical presentation:
376
